ROSEMONT, Illinois, Dec. 9 -- Annals of Surgical Oncology, a peer-reviewed journal from the Society of Surgical Oncology that says it features all aspects of the surgical treatment of cancer, published research articles on the following topics in its January 2024 edition (Vol. 31, Issue 1):

* Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know?
. . .

Click here for more information about our products